About T-Cell Lymphoma
T-cell lymphoma develops when T-cells (T-lymphocytes) become abnormal and multiply uncontrollably. The exact causes of T-cell lymphoma are not fully understood, but there are some factors that may increase the risk of developing the condition.
Non-modifiable risk factors (factors a person cannot change or control):
- Age: T-cell lymphoma is more commonly found in individuals who are 50 years and older.
- Sex assigned at birth: T-cell lymphoma is more frequently diagnosed in males than females.
- Weakened immune system: Having a weakened immune system can increase the risk of developing T-cell lymphoma. This may be due to medical conditions, such as autoimmune conditions, or immunosuppressive medications.
- Race: People who are white or Asian have a higher risk of developing T-cell lymphoma than people who are Black.
Modifiable risk factors:
- Infections: Certain viral infections, such as HTLV-1 virus or Epstein-Barr virus (EBV), can also increase the risk. Viral reactivation of viruses may be linked to T-cell lymphoma.
- Exposure to carcinogens: Exposure to UV light or certain chemicals increase the risk of certain T-cell lymphomas.
It's important to note that these risk factors do not guarantee the development of T-Cell Lymphoma, but they may increase the likelihood. If you have concerns about your risk or symptoms, it's best to consult with a healthcare professional for personalized advice and guidance.
The most common early symptoms of T-Cell Lymphoma include:
- Swollen lymph nodes
- Fever
- Unexplained weight loss
- Severe night sweats
- Skin rashes or itching
- Persistent (constant) fatigue
Based on the location of T-cell lymphoma or as it progresses, additional symptoms may occur, such as:
- Enlarged liver and spleen
- Weakness
- Fluid buildup in the abdominal cavity or around the lungs
- Swelling in the legs, skin around the eyes, or conjunctiva (membrane covering the eye)
- High white blood cell counts
- Low red blood cell counts (anemia)
- Low platelet counts
It's important to note that these symptoms can vary depending on the individual, subtype of T-Cell Lymphoma, and disease severity. If you experience any unusual symptoms, it is recommended to visit a doctor for further evaluation and diagnosis.
To diagnose T-cell lymphoma, the following examinations, tests, and procedures are commonly performed:
- Medical history: The healthcare provider will gather information about symptoms, medical conditions, medications, family medical history, and history of viral illnesses or exposure to potential carcinogens.
- Physical exam: The healthcare provider will look for physical signs such as swollen lymph nodes, abdominal tenderness, enlarged spleen or liver, or other masses in the body.
- Blood tests: Blood studies may be performed to:
- Measure the amounts of certain substances released into the blood by organs and tissues in the body
- Check the function of the liver. This is done by measuring specific substances released by the liver. Unusual amounts of these substances can be indicators of cancer.
- Look at the blood cells under a microscope.
- Check for signs of past or current viral infection.
- Imaging studies: Magnetic resonance imaging (MRI) scans or positron emission tomography (PET) scans can provide detailed images of the organs and other structures inside the body to detect any abnormalities.
- Biopsy: A small sample of tissue is taken from the bone marrow or tumor for examination under a microscope to confirm the diagnosis and determine the specific type of T-cell lymphoma.
The staging of T-cell lymphoma may differ based on the type of T-cell lymphoma. In general, stages of T-cell lymphoma are:
- Stage 1: Lymphoma is in one lymph node area or one lymphoid organ (bone marrow, thymus, or spleen).
- Stage 2: Lymphoma is in in two or more groups of lymph nodes located on the same side of the diaphragm (either above the diaphragm or below the diaphragm).
- Stage 3: Lymphoma is in lymph nodes on both sides of the diaphragm (both above and below the diaphragm) or in the spleen.
- Stage 4: Lymphoma in at least one organ outside the lymphatic system, such as the liver or lung.
It's important to follow up with your healthcare provider if your symptoms worsen or change after the initial physical exam. They will recommend specific tests based on your individual situation.
The goals of treatment for T-cell lymphoma are to achieve remission, control the disease, relieve symptoms, and improve overall quality of life. Goals may depend on the type and stage of T-cell lymphoma. The following are the treatment options and how they work to achieve these goals:
In some cases of slow-growing types of T-cell lymphoma that isn’t causing symptoms, the healthcare professional may recommend a period of watchful waiting before treatment. During watchful waiting, the healthcare team monitors the condition and starts treatment when symptoms appear.
Medications:
- Chemotherapy: Chemotherapy uses drugs to kill cancer cells or stop them from growing. The specific chemotherapy medications used will depend on the type and stage of T-cell lymphoma. A combination of chemotherapy drugs may be used. Chemotherapy may be given in cycles, which allows the body to recover from chemotherapy side effects between cycles. Chemotherapy can be given orally or through intravenous infusion.
- Targeted therapies: These therapies target specific proteins or enzymes needed by cancer cells to continue to survive or grow. They disrupt a cancer cell’s function or processes needed to divide, multiply, or spread. An example of targeted therapy includes monoclonal antibody therapy.
- Immunotherapy: These drugs help boost the body's immune system to fight cancer cells. It may involve using medications that enhance immune responses or antibodies that specifically target cancer cells. The intended impact of immunotherapy is to help the immune system recognize and attack cancer cells more effectively. An example of immunotherapy includes CAR T-cell therapy. Some monoclonal antibodies are also considered immunotherapy.
- Radiation therapy: Radiation therapy uses high-energy beams to target and kill cancer cells. It may be used for certain types of T-cell lymphoma, such as when the lymphoma is only in one area. It may be used alone or in combination with other treatments, such as chemotherapy or immunotherapy. The intended impact of radiation therapy is to destroy cancer cells in a specific area of the body.
- Light Therapy: UVA and UVB light combined with psoralens may be used for T-cell lymphomas that affect the skin to kill cancer cells on the skin.
- Stem cell transplantation: This procedure may be recommended for some people with NHL. It involves replacing damaged or diseased stem cells (the immature cells that normally become red blood cells, white blood cells, and platelets) with healthy stem cells.
- Supportive treatments: Additional medications or therapies may be used as part of the treatment plan. Examples include:
- Medications to help reduce nausea or vomiting or to help reduce the risk of infections.
- Pain medications
- Medications to help stimulate appetite
- Antibiotics to prevent or treat infection
- Lifestyle behavior modifications are not considered primary treatments for T-cell lymphoma. However, smoking cessation, alcohol moderation, nutrition and diet changes, and activity changes can contribute to overall health and well-being and can support overall treatment outcomes.
It's important to note that treatment plans may vary depending on individual patient factors. Always consult with a healthcare professional for personalized advice.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.